Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Dri Healthcare Trust

Headquarters: Toronto, Canada
Year Founded: 1989
Status: Private

BioCentury | Oct 7, 2024
Deals

AstraZeneca, Hong Kong-based CSPC in deal for dyslipidemia therapy

Deals report: Recordati acquires Enjaymo from Sanofi, and updates from BioMarin-Camp4, Editas-DRI and more
BioCentury | Oct 4, 2022
Finance

Oct. 3 Quick Takes: Myovant open to sweeter Sumitovant proposal

Plus Alloy raises series D and updates from Omeros, NeuShen
BioCentury | Jul 22, 2022
Finance

July 21 Quick Takes: Verve raises $225M on back of Vertex deal, clinical milestone

Plus Biogen resolving kickback claim, ARS reverse-merging with Silverback and more
BioCentury | Mar 1, 2022
Deals

Feb. 28 Quick Takes: Heidelberg shares jump as Huadong takes stake

Plus FDA approves CTI’s pacritinib, Aurinia shares sink, Lexicon submission delayed, priority review for neoadjuvant Opdivo and more
BioCentury | Aug 28, 2021
Product Development

Aug. 27 Quick Takes: BioMarin gains first worldwide approval for achondroplasia therapy

Plus: Roche’s Tecentriq withdrawal, a16z’s seed fund, Lynk’s venture round and more
Items per page:
1 - 5 of 5